Improving Human Papillomavirus-Related Cervical Cancer Screening in Patients With Systemic Lupus Erythematosus.
Tiphaine GoulenokCéline MendesLéa DayanValentine Marie FerreMargot BucauFatima FarhiThomas PapoKarim SacrePublished in: The Journal of rheumatology (2023)
Women with systemic lupus erythematosus (SLE), especially when exposed to immunosuppressive drugs, are at higher risk of human papillomavirus (HPV)-related cervical cancer. 1 A recent study has shown that cervical cancer screening (CCS) coverage is worryingly low in this population. 2 .